[New trends in the therapy of myeloma].
Jantunen
E
E
KYS:n sisätautien klinikka PL 1777, 70211 Kuopio.
Nousiainen
T
T
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D016026:Bone Marrow Transplantation; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D004164:Diphosphonates / Q000627:therapeutic use; D020847:Estrogen Receptor Modulators / Q000627:therapeutic use; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy / Q000628:therapy*; D013792:Thalidomide / Q000627:therapeutic use
D020533:Angiogenesis Inhibitors; D004164:Diphosphonates; D020847:Estrogen Receptor Modulators; D013792:Thalidomide